Reid Hoffman to leave Microsoft board to focus on AI drug discovery startup Manas AI
Posted On June 6, 2026
Hoffman’s shift from Microsoft’s board to AI drug discovery highlights a growing trend of tech leaders prioritizing health innovation.
The post Reid Hoffman to leave Microsoft board to focus on AI drug discovery startup Manas AI appeared first on Crypto Briefing.
About The Author
